...
首页> 外文期刊>Epidemiology >Hypertension and risk of renal cell carcinoma among white and black Americans.
【24h】

Hypertension and risk of renal cell carcinoma among white and black Americans.

机译:白人和黑人美国人的高血压和肾细胞癌的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Renal cell carcinoma and hypertension (a well-established renal cancer risk factor) are both more frequent among blacks than whites in the United States. The association between hypertension and renal cell carcinoma has not been examined in black Americans. We investigated the hypertension-renal cancer association by race, and we assessed the role of hypertension in the racial disparity of renal cancer incidence. METHODS: Participants were enrolled in a population-based case-control study in Detroit and Chicago during 2002-2007 (number of cases: 843 whites, 358 blacks; number of controls: 707 whites, 519 blacks). Participants reported their history of hypertension and antihypertensive drug use. We used unconditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for demographic characteristics, smoking, body mass index, and family history of cancer. RESULTS: Hypertension doubled renal cancer risk (OR = 2.0 [CI = 1.7-2.5]) overall. For whites, the OR was 1.9 (CI = 1.5-2.4), whereas for blacks it was 2.8 (2.1-3.8) (P for interaction = 0.11). ORs increased with time after hypertension diagnosis (P for trend <0.001), reaching 4.1 (CI = 2.3-7.4) for blacks and 2.6 (CI = 1.7-4.1) for whites after 25 years. ORs for poorly controlled hypertension were 4.5 (CI = 2.3-8.8) for blacks and 2.1 (CI = 1.2-3.8) for whites. If these estimates correctly represent causal effects and if, hypothetically, hypertension could be prevented entirely among persons aged 50-79 years, the black/white disparity in renal cancer could be reversed among women and reduced by two-thirds among men. CONCLUSIONS: Hypertension is a risk factor for renal cancer among both blacks and whites, and might explain a substantial portion of the racial disparity in renal cancer incidence. Preventing and controlling hypertension might reduce renal cancer incidence, adding to the known benefits of blood pressure control for heart disease and stroke reduction, particularly among blacks.
机译:背景:在美国,黑人中的肾细胞癌和高血压(公认的肾癌危险因素)都比白人更为常见。尚未在美国黑人中检查高血压与肾细胞癌之间的关联。我们通过种族调查了高血压-肾癌的关系,并评估了高血压在肾癌发病率种族差异中的作用。方法:参加者于2002-2007年在底特律和芝加哥参加了一项基于人群的病例对照研究(病例数:843名白人,358名黑人;对照组人数:707名白人,519名黑人)。参加者报告了其高血压和使用降压药的历史。我们使用无条件逻辑回归来计算比值比(OR)和95%置信区间(CIs),并根据人口统计学特征,吸烟,体重指数和癌症家族史进行了调整。结果:总体而言,高血压使肾癌的风险加倍(OR = 2.0 [CI = 1.7-2.5])。对于白人,OR为1.9(CI = 1.5-2.4),而对于黑人,OR为2.8(2.1-3.8)(互动P = 0.11)。高血压诊断后的OR随时间增加(趋势<0.001的P),黑人25年后达到4.1(CI = 2.3-7.4),白人达到2.6(CI = 1.7-4.1)。黑人的高血压控制不佳的OR为4.5(CI = 2.3-8.8),白人为2.1(CI = 1.2-3.8)。如果这些估计正确地代表了因果关系,并且假设可以完全预防50-79岁人群的高血压,那么女性肾癌的黑白差异可以逆转,而男性则可以减少三分之二。结论高血压是黑人和白人中患肾癌的危险因素,可能解释了肾癌发病率种族差异的很大一部分。预防和控制高血压可能会降低肾癌的发病率,增加血压控制对心脏病和中风减少的已知益处,尤其是在黑人中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号